News & Events

Xplico participates in international congresses and events 6-8 times a year in Europe and the US, so there are plenty of opportunities to meet up with us.

We would be delighted to give you a presentation of our products and services and/or to discuss your specific needs, so please do not hesitate to book a meeting, either during a conference or at a time convenient for you, to discuss how you can benefit from our valuation and consulting services.


BIO EUROPE SPRING, Milan, Italy, March 17-19, 2025.

BIO-Europe is the gateway to the global biopharma community and celebrates 30 years of facilitating partnerships. The conference convenes over 5,500 attendees, representing 60 countries and 2,800+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.

(January 2025)

LSX World Congress, London, UK, April 28-30, 2025.

The LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.

The event brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.

LSX Nordic Congress, Bergen, Norway, May 20-21, 2025.

The LSX Nordic Congress connects life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic & Baltic life science and healthcare innovation.

The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.

(January 2025)

BIO International Convention, Boston, USA, June 16-19, 2025.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. The proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

(January 2025)

LSX World Congress, Boston, USA, September 16-17, 2025.

The LSX World Congress USA gathers leaders from the US biotech, medtech, and healthtech sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology.

(January 2025)

Nordic Life Sciences Days, Gothenburg, Sweden, October 13-14, 2025.

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business.

(January 2025)

BIO-EUROPE, Vienna, Austria, November 3-5, 2025.

BIO-Europe is the gateway to the global biopharma community and celebrates 30 years of facilitating partnerships. The conference convenes over 5,500 attendees, representing 60 countries and 2,800+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.

(January 2025)

Xplico elected a Gazelle Company for the 4th year in a row

We are proud to announce that Xplico has been elected a Gazelle company for the 4th year in a row.

The election is organized by the Danish financial newspaper Børsen, and the requirements to become a Gazelle company are tough. A Gazelle business is continuously growing and, as a minimum, doubles its revenue or gross profit over four fiscal years, while maintaining positive growth throughout the years.

(October 2019)

Publication of the Xplico Valuation Survey

In July and August 2018 Xplico conducted a survey among 600 industry professionals about valuation in the life science industry and received 79 responses. We hereby present the results of the survey.
(November 2018)

Xplico article for Biotech & Money / LSX

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Finn Nikolajsen, gives his point of view on the challenges of the ownership structures that the biotech companies and their investors face when they try to analyze the consequences of current and future funding rounds and exits.


(October 2018)

Xplico article for Biotech & Money / LSX

In an article for Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, gives his point of view on the challenges that the Nordic life science companies face.

(August 2018)

Xplico Interview with Biotech & Money / LSX

In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, explains how valuation is critical for strategic decision-making and points out to some of the common pitfalls companies encounter when using valuation models that are built in house.


(June 2018)